[Federal Register Volume 82, Number 142 (Wednesday, July 26, 2017)]
[Notices]
[Pages 34672-34673]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-15671]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30 Day-17-1128]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agency's estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention:

[[Page 34673]]

CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 
or by fax to (202) 395-5806. Written comments should be received within 
30 days of this notice.

Proposed Project

    State Unintentional Drug Overdose Reporting System (SUDORS) (OMB 
Control Number 0920-1128, exp. 8/31/2018)--Revision--National Center 
for Injury Prevention and Control (NCIPC), Centers for Disease Control 
and Prevention (CDC).

Background and Brief Description

    In 2013, there were nearly 44,000 drug overdose deaths, including 
nearly 36,000 unintentional drug overdose deaths, in the United States. 
More people are now dying of drug overdose than automobile crashes in 
the US. A major driver of the problem are overdoses related to opioids, 
both opioid pain relievers (OPRs) and illicit forms such as heroin. In 
order to address this public health problem, the U.S. Department of 
Health and Human Services (HHS) has made addressing the opioid abuse 
problem a high priority.
    In order to support targeting of drug overdose prevention efforts, 
detect new trends in fatal unintentional drug overdoses, and assess the 
progress of HHS's initiative to reduce opioid abuse and overdoses, the 
State Unintentional Drug Overdose Reporting System (SUDORS) conducts 
ongoing surveillance of fatal unintentional opioid-related drug 
overdoses to support prevention and response efforts in states with a 
high burden of opioid-related overdoses. This collection generates 
public health surveillance information on unintentional fatal opioid-
related drug overdoses at the national, state, and local levels that is 
more detailed, useful, and timely than is currently available. This 
information will help develop, inform, and assess the progress of drug 
overdose prevention strategies at the national, state, and local 
levels.
    SUDORS will collect information that is not currently collected on 
death certificates such as whether the drug(s) causing the overdoses 
were injected or taken orally, a toxicology report on the decedent, if 
available, and risk factors for fatal drug overdoses including previous 
drug overdoses, decedent's mental health, and whether the decedent 
recently exited a treatment program. Without this information, drug 
overdose efforts are often based on limited information available on 
the death certificate and anecdotal evidence.
    CDC is expanding the state opioid surveillance program to include 
additional states. In fiscal year 2016, CDC was appropriated funds to 
work with state health departments to improve the timeliness of fatal 
opioid overdose surveillance by developing the Enhanced State Opioid 
Overdose Surveillance program (ESOOS), with 16 states originally 
approved. ESOOS provides states a delivery schedule for reporting fatal 
opioid overdoses to CDC using SUDORS. In fiscal year 2017, ESOOS 
received a significant increase in funding through congressional 
appropriation to expand the number of states using the SUDORS OMB 
package for mortality data collection. The next data delivery will 
occur in October 2017. As a result, CDC now requests OMB approval for 
three years for this revision to include all 50 states.
    The purpose of the revision is twofold: (1) Increase burden hours 
associated with increasing the number of states using the SUDORS OMB 
package from the 16 approved to all 50 states; and (2) implement 
updates to the web-based system to improve performance, functionality, 
and accessibility as well as minimal revisions to the SUDORS collection 
instrument. Minimal changes to the SUDORS module include revisions to 
question wording and response choices, as well as additional categories 
available to capture information that previously could only be captured 
in a narrative field, to better capture contextual information such as 
day/time a decedent was last seen alive, whether a decedent had a 
recent opioid use relapse, evidence of prescription drug use, and 
evidence of rapid overdose. These changes would not affect burden hours 
per response, the increase in burden hours is associated with 
increasing the number of states using the SUDORS OMB package from the 
16 approved to all 50 states.
    Participation is based on secondary data and is dependent on 
separate data collection efforts in each state managed by the state 
health departments or their bona fide agent. The estimated annual 
burden hours are 16,550 with an increase of 9,542 burden hours from the 
previously approved collection. There are no costs to respondents.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                   Total number       Average
                                                     Number of     of responses     burden per     Total burden
      Type of respondent            Form name       respondents         per        response  (in    hours  (in
                                                                    respondent        hours)          hours)
----------------------------------------------------------------------------------------------------------------
Public Agencies...............  Retrieving and                50             662           30/60          16,550
                                 refile records.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............          16,550
----------------------------------------------------------------------------------------------------------------


Leroy Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-15671 Filed 7-25-17; 8:45 am]
 BILLING CODE 4163-18-P